DAFTAR PUSTAKA

1. Agarwal SK. Biologic agents in rheumatoid arthritis: an update for managed care

professionals. J Manag Care Pharm. 2011;17(9):14-8.

2. Carla B, Virginia R Mariona P. Is there potential for therapeutic drug monitoring of

biologic agents in rheumatoid arthritis?. Br J Clin Pharmacol. 2017; 83: 962–75.

3. Jeffrey R. C and Jasvinder A S. The Use of Biologics in Rheumatoid Arthritis: Current

and Emerging Paradigms of Care. Clin Ther. 2011: 33(6): 679–707.

4. CDK. Guideline EULAR 2013 untuk Penanganan Rheumatoid Arthritis. CDK.2014; 41

(6): 467.

5. Sukandar. ISO Farmakoterapi. Jakarta: PT ISFI Penerbitan, 2009.

6. Gibofsky. Overview of Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid

Arthritis, The American Journal of Managed Care. 2012; 18(13) :295-302.

7. Mark B, Nermeen M and Rashid K. Retrospective cohort study of anti-tumor necrosis

factor agent use in a Veteran Population. PeerJ.2014; 1(1):1-22.

8. Perhimpunan Reumatologi Indonesia. Rekomendasi Perhimpunan Reumatologi Indonesia

Untuk Diagnosis dan Pengelolaan Artritis Reumatoid. Jakarta: Perhimpunan Reumatologi

Indonesia,2014.

9. Kevin D. D, M. Kristen D, Lindsay B. K, et al. Genetic and environmental risk factors for

rheumatoid arthritis. Best Practice & Research Clinical Rheumatology.2017;31(1): 3-18.

10. Marc. Hypersensitivity Reactions and Methods of Detection, Neuroscience. 2009; 372:

1-4.

11. Mclnnes. The Pathogenesis of Rheumatoid Arthritis, N Engl j med. 2011; 365 : 2205-

2219.
12. Scott. Rheumatoid arthritis, Lancet.2010; 376: 1094-1108.

13. Ursum. Different Properties Of ACPA and Igm-RF Derived From A Large Dataset:

Further Evidence Of Two Distinct Autoantibody Systems. Rhinitis Research and

Therapy. 2010; 11 (3): 1-6.

14. AHRQ. Rheumatoid Arthritis Medicines: A Guide for Adults, diakses pada

http://www.effectivehealthcare.ahrq.gov/repFiles/RheumArthritisConsumerGuide_Singl

epage.pdf tanggal 8 Juli 2018.

15. NHS. Symptoms Of Rheumatoid Arthritis, diakses pada

http://www.nhs.uk/Conditions/Rheumatoid-arthritis/Pages/Symptoms.aspx tanggal 8

Juli 2018.

16. Aleteha, D., Neogi T., Silman, A.J., et al.Rheumathoid Arthritis Classification Criteria :

An American College Of Rheumathology/European League Against Rheumatism

Collaborative Initiative. Arthritis Rheum. 2010; 62(9): 2569-81.

17. Singh, J.A., et al. Update of the 2008 American College of Rheumatology

Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic

Agents in the Treatment of Rheumatoid Arthritis, Arthritis Care & Research. 2012; 64 (

5): 625–39.

18. Curtis, Jeffrey R. and Singh, J.A. The Use of Biologics in Rheumatoid Arthritis: Current

and Emerging Paradigms of Care. Clin Ther. 2011 June ; 33(6): 679–707

19. CDK. Penanganan Rheumatoid Arthritis (RA): Pendekatan Agresif dengan Kontrol Ketat.

CDK.2011; 38 .(4) : 288.

20. Philipp R, Ruediger B. M. Treatment with Biologicals in Rheumatoid Arthritis: An

Overview. Rheumatol Ther.2017; 4:247–61.

21. Patrick D. WK, Chris D, Josh D et al. Biologic agents for rheumatoid arthritis—
negotiating the NICE technology appraisals. Rheumatology 2012;51:24-31.